DNA Diagnostics Center®, an Established Global Leader in Diagnostic and Genetic Testing, Names Scott Cramer President and Chief Executive Officer
February 05, 2019 08:00 ET | DDC DNA
Fairfield, OH, Feb. 05, 2019 (GLOBE NEWSWIRE) -- The Board of Directors of DNA Diagnostics Center® (DDC®) announces that Scott Cramer has joined DDC as president, chief executive officer, and a...
MFB Fertility Launches Proov™, the First-Ever Home Progesterone Test for Fertility and Ovulation Tracking
October 26, 2018 12:23 ET | MFB Fertility
BOULDER, Colo, Oct. 26, 2018 (GLOBE NEWSWIRE) -- MFB Fertility, Inc., a Boulder-based medical company created to empower women to know more about their reproductive health, today announced the...
Reproductive rights
Reproductive rights key to economic development, new UNFPA report shows
October 17, 2018 00:01 ET | UNFPA
UNITED NATIONS, New York, Oct. 17, 2018 (GLOBE NEWSWIRE) -- The global trend towards smaller families is a reflection of people making reproductive choices to have as few or as many children as they...
Fertility Testing De
Fertility Testing Devices Market Worth USD 264.93 billion by 2023
December 06, 2017 09:04 ET | Crystal Market Research
LAS VEGAS, Dec. 06, 2017 (GLOBE NEWSWIRE) -- A research study titled, “Fertility Testing Devices Market By Product and Mode of Purchase- Global Industry Analysis and Forecast to 2023” published by...
Progyny Logo 2022 no tag.png
Progyny Expands its Clinical Leadership, adding Alan B. Copperman, M.D., FACOG as Medical Director
October 02, 2017 09:30 ET | Progyny
NEW YORK, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits company, today announced that Alan B. Copperman, M.D., FACOG has joined the Company as Medical Director. In his...
Agile_Logo-color on white.jpg
Agile Therapeutics to Present Additional Phase 3 Data at the 73rd Annual Congress of the American Society for Reproductive Medicine
September 07, 2017 07:50 ET | Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that an abstract presenting data from the Phase 3 SECURE...
Progyny Logo 2022 no tag.png
Progyny Named to the 2017 CNBC Disruptor 50 List
May 16, 2017 09:44 ET | Progyny
NEW YORK, May 16, 2017 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits company, today announced that it was named #13 on CNBC’s fifth annual Disruptor 50 List. The rapidly growing...
Progyny Logo 2022 no tag.png
Progyny Raises $10 Million to Support Strong Growth of Fertility Benefits Business
May 02, 2017 05:00 ET | Progyny
NEW YORK, May 02, 2017 (GLOBE NEWSWIRE) -- Progyny, a leading fertility benefits company, today announced that the company has secured $10 million in Series B extension financing to support its...
Hamilton Thorne and BCSI to Launch Incubator Retrofit Service for the Fertility and Developmental Biology Markets
January 04, 2017 08:30 ET | Hamilton Thorne; BCSI
BEVERLY, MA and TORONTO, ON--(Marketwired - Jan 4, 2017) - Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision instruments, consumables, software and services, and Blood Cell...
Hamilton Thorne to Present at the 2016 LD Micro Main Event
November 30, 2016 08:30 ET | Hamilton Thorne
BEVERLY, MA and TORONTO, ON--(Marketwired - Nov 30, 2016) - Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted...